Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis

Biochemical and Biophysical Research Communications
R M StrieterP J Polverini

Abstract

Angiogenesis is fundamental to a variety of physiological and pathological processes. While a number of factors have been identified that induce neovascularization, it is becoming increasingly apparent that endogenous angiostatic factors may play an important role in the regulation of angiogenesis during wound repair, chronic inflammation, and growth of solid tumors. In this study, we demonstrate the novel finding that IP-10, a member of the C-X-C chemokine family, is a potent inhibitor of both IL-8 and bFGF-induced angiogenic activity using in vitro and in vivo assays of angiogenesis. These findings support the contention that IP-10 may be a pivotal cytokine in the regulation of neovascularization.

Citations

Jun 15, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jinming Yang, Ann Richmond
Jul 5, 2001·Neuropathology and Applied Neurobiology·S H GoldbergE Lavi
Dec 22, 1998·The Journal of Experimental Medicine·S E PikeG Tosato
Jan 19, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·K PalmerJ Gauldie
May 13, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kevin L TaylorDaniel J Lindner
Oct 22, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kevin L TaylorDaniel J Lindner
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Jun 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Asa AnderssonSherven Sharma
Feb 25, 2003·American Journal of Respiratory and Critical Care Medicine·Suhas G KallapurCindy J Bachurski
Aug 26, 1999·American Journal of Respiratory Cell and Molecular Biology·I CaminschiB Scott
Jun 19, 2004·American Journal of Respiratory Cell and Molecular Biology·Andrew M TagerAndrew D Luster
Feb 19, 2011·American Journal of Respiratory Cell and Molecular Biology·Robert M TighePaul W Noble
Oct 7, 2004·The Journal of Clinical Investigation·Kazuhide WatanabeYasufumi Sato
Aug 6, 1998·The Journal of Clinical Investigation·D A ArenbergR M Strieter
Nov 3, 2005·BMC Cell Biology·Christina L AddisonChristie E Delaney
Sep 9, 1999·Bioscience, Biotechnology, and Biochemistry·T MatsunagaK Hirano
Sep 22, 2010·PloS One·Gabriele S V CampanellaAndrew D Luster
Feb 18, 2014·Cytokine & Growth Factor Reviews·Alessandro AntonelliPoupak Fallahi
Nov 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·E TzimaP Schimmel
Jul 27, 1999·Gastroenterology·M B DwinellM F Kagnoff
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·C SgadariG Tosato
May 9, 2000·Critical Reviews in Oncology/hematology·M Hagedorn, A Bikfalvi
Aug 17, 2000·Springer Seminars in Immunopathology·C FonsecaC M Black
Dec 6, 2008·World Journal of Surgery·Timothy R Donahue, O Joe Hines
Dec 18, 2002·Cytokine & Growth Factor Reviews·Andrei Thomas-Tikhonenko, Christopher A Hunter
Dec 27, 2005·Annals of Surgical Oncology·Elizabeth D FeldmanH Richard Alexander
Apr 13, 2010·Clinical & Experimental Metastasis·Adriana AlbiniUlrich Pfeffer
Oct 24, 2008·International Journal of Clinical Oncology·Jiro Fujimoto
Jun 16, 2012·Cell and Tissue Research·Anne Jaerve, Hans Werner Müller
Oct 19, 2007·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Francesca GotschSonia S Hassan
Nov 28, 2000·Expert Opinion on Investigational Drugs·M W LingenJ I Clark
Dec 1, 2001·Expert Opinion on Biological Therapy·T G Zogakis, S K Libutti
Jun 25, 2002·Expert Opinion on Biological Therapy·Jon M Wigginton, Robert H Wiltrout
Jul 5, 2005·Expert Opinion on Investigational Drugs·P D Ponath
Oct 14, 2014·Current Eye Research·Gaoqin LiuPeirong Lu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.